Patent 9737530 was granted and assigned to Collegium Pharmaceutical on August, 2017 by the United States Patent and Trademark Office.
The present disclosure relates to cured pharmaceutical compositions designed to reduce the potential for improper administration of drugs that are subject to abuse, the process of curing such composition in order to improve the dissolution stability, method of using the same for treatment of pain.